Welcome to MiNDToolkit

A novel online platform for management of non-motor symptoms in Motor Neurone Disease

Learn more

MiNDToolkit is a novel psychoeducational research platform

We successfully completed a feasibility trial, which was a study investigating if the MiNDToolkit was acceptable for carers and healthcare professionals. This feasibility study also investigated if it was feasible to use MiNDToolkit in NHS settings and in a future larger national trial. The feasibility study confirmed that MiNDToolkit was acceptable to both family carers and healthcare professionals, and that the MiNDToolkit was feasible to be tested in a larger national randomised controlled trial. We are now currently trying to secure research funding for the national randomised controlled trial, so that we can test the platform efficacy in supporting carers in the future. Efficacy testing will investigate questions like: does MiNDToolkit help carers better manage behavioural symptoms in MND? Does MiNDToolkit help carers feel better skilled as carers?

Behavioural changes

Up to 50% of people with MND experience behavioural changes

Carer support

Behavioural changes are associated with greater stress in carers

Multifaceted platform for management of behavioural changes in Motor Neurone Disease

Carers

such as family members, friends, paid carers can have access to a personalized symptom management plan for the duration of the research study

Healthcare professionals

can access training for management of behavioural symptoms to support carers and improve their practise

Researchers

monitor and manage the MiNDToolkit research study in the background

Integration

the MiNDToolkit brings together carers and healthcare professionals into one platform

Feasibility study results

Please click here to learn more about our feasibility study results

Dissemination of the MiNDToolkit

Please click here to learn more about all events where we have presented about MiNDToolkit

Study results & Dissemination of the MiNDToolkit

  • Carers told us that learning about behavioural symptoms was like a ‘lightbulb moment’. Carers who used MiNDToolkit were interviewed at the end of the study. What they said was analysed following rigorous methodology. Carers’ experience of behavioural symptoms was particularly distressing when symptoms were apparently out of context, i.e., they did not know they were common symptoms in MND. However, MiNDToolkit appeared to support learning that behavioural symptoms were part of MND.

    Content of MiNDToolkit resonated with carers, who reported learning about the full picture of MND, which led to acceptance and use of newly learned strategies. Engagement with the platform was good.

    Greater and nuanced involvement from HCPs seem important to support management of behavioural symptoms. For future studies, carers suggested including adding a paper booklet to accompany the intervention and creation of new modules on emotional lability, changes in relationships, and transitioning to a care home.

    Full details on the scientific results can be found here.

  • Healthcare professionals said that MiNDToolkit was a beneficial and acceptable resource for them, with potential to increase knowledge and confidence for their work with MND families. Professionals also said that MiNDToolkit could help them in better recognise, identify and manage behavioural symptoms in MND.

    However, some professionals were worried that raising questions about behavioural symptoms would be burdensome to carers – for this reason, sometimes they did not raise the potential presence of behavioural symptoms in their appointments with the families. Professionals also thought that family carers would take the initiative to ask for support from clinicians instead. Unfortunately, it appears that many carers do not know about behavioural symptoms and therefore cannot ask about something that they do not fully know. Carers may mistake behavioural symptoms, such as lack of empathy, as emotional reactions from the person with MND. This can be hurtful if symptoms are severe.

    Read more about the family carers’ perspectives above.

    Full details on the scientific results of the study on healthcare professionals can be found here.

  • This means that we can now test the MiNDToolkit with a larger number of carers, to find out if MiNDToolkit can do what it is intended to do (efficacy). MiNDToolkit targets carers’ skills in managing behavioural symptoms in MND, and also targets carers’ skills in looking after themselves well, which is technically called ‘carer self-efficacy’.

    Full details on the scientific results can be found here.

Events

  • A group of us travelled to Montreal to take part in the ALS/MND Symposium. Our Patient Public Involvement and Engagement lead, Sue Heal, joined us. You can read her experience here.

    Professor Eneida Mioshi (left), Sue Heal (middle) and Dr Polly Trucco at the 35th International Symposium.

  • October 2024: MND Association Community of Practice Annual Meeting, Birmingham, UK
  • June 2024: MND Association Care Centres Coordinator Meeting, Leicester, UK
  • We travelled to Barcelona to take part in the ENCALS annual meeting

    Our MiNDToolkit process evaluation lead, Dr Thando Katangwe-Chigamba, presented findings from the MiNDToolkit.

  • March 2024: SouthEast MND Network Study Day, Tunbridge Wells, UK
  • February 2024: UMC Utrecht, The Netherlands (online)
  • January 2024: MND Association Webinar, Community of Practice, UK (online)
  • December 2023: 34th ALS/MND International Symposium, Basel, Switzerland
  • A fully hybrid meeting was held in London.

    Professionals involved in MiNDToolkit, and research colleagues, joined us to hear the main results from the feasibility trial.

    Prof Sharon Abrahams was our keynote speaker

Frequently Asked Questions

Our participating sites from the MiNDToolkit feasibility study

Our research team

Eneida Mioshi

Lead Investigator, UEA

Helen Copsey

MND Specialist, Norfolk MND Care and Research Network

Michael Hornberger

Co-Investigator, UEA

Lee Shepstone

Co-Investigator, UEA

Emma Flanagan

Junior Manager, Norwich Clinical Trials Unit

Polly-Anna Ashford

Senior Manager, Norwich Clinical Trials Unit

Funded and supported by

Contact us

Location:

University of East Anglia

Loading
 Could not send message
 Your message has been sent. Thank you!